DIA415.36+6.58 1.61%
SPX5,638.94+117.42 2.13%
IXIC17,754.09+451.07 2.61%

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga·03/14/2025 17:05:44
Listen to the news

Gainers

  • Akebia Therapeutics (NASDAQ:AKBA) shares rose 31.6% to $2.23 during Friday's regular session. The company's market cap stands at $485.4 million. The company's, Q4 earnings came out yesterday.
  • Syros Pharmaceuticals (NASDAQ:SYRS) stock rose 29.54% to $0.1. The company's market cap stands at $2.6 million.
  • Biote (NASDAQ:BTMD) stock increased by 24.59% to $3.83. The market value of their outstanding shares is at $119.0 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Firefly Neuroscience (NASDAQ:AIFF) stock rose 20.52% to $4.17. The market value of their outstanding shares is at $33.6 million.
  • Scienture Holdings (NASDAQ:SCNX) stock moved upwards by 19.35% to $1.48. The market value of their outstanding shares is at $12.7 million.
  • Aclarion (NASDAQ:ACON) shares rose 17.88% to $0.81.

Losers

  • Sutro Biopharma (NASDAQ:STRO) shares declined by 29.6% to $0.88 during Friday's regular session. The market value of their outstanding shares is at $72.5 million.
  • NeueHealth (NYSE:NEUE) stock declined by 28.08% to $4.76. The company's market cap stands at $39.4 million.
  • Dogwood Therapeutics (NASDAQ:DWTX) shares fell 23.29% to $5.93. The company's market cap stands at $7.8 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock fell 17.64% to $0.1. The company's market cap stands at $1.5 million.
  • Atlantic International (NASDAQ:ATLN) shares decreased by 16.0% to $5.04. The market value of their outstanding shares is at $313.6 million.
  • Polyrizon (NASDAQ:PLRZ) shares decreased by 15.56% to $0.57. The market value of their outstanding shares is at $2.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.